keyword
https://read.qxmd.com/read/38724237/an-open-label-single-arm-prospective-multi-center-tandem-two-stage-designed-phase-ii-study-to-evaluate-the-efficacy-of-fulvestrant-in-women-with-recurrent-metastatic-estrogen-receptor-positive-gynecological-malignancies-fuchsia-study
#1
JOURNAL ARTICLE
Rita Trozzi, Sandra Tuyaerts, Daniela Annibali, Alejandro Herreros Pomares, Lotte Boog, Peter Van Dam, Karin Leunen, Christophe Deroose, Hans Trum, Frédéric Amant
OBJECTIVE: This study aimed to evaluate fulvestrant efficacy in women with estrogen receptor-positive low-grade gynecological cancers. The primary objective was to determine the response rate. Secondary objectives were progression-free survival, clinical benefit, duration of response, safety, tolerability, and quality of life. METHODS: FUCHSia is an open-label, single-arm, prospective, multi-center phase II study. The study population included patients with recurrent/metastatic low-grade gynecological malignancies with estrogen receptor positivity who received a maximum of two lines of previous hormonal therapy...
May 9, 2024: International Journal of Gynecological Cancer
https://read.qxmd.com/read/38716772/clinical-actionability-of-brca2-alterations-in-uterine-leiomyosarcoma-a-molecular-tumor-board-case-report-and-a-cbioportal-comprehensive-analysis
#2
JOURNAL ARTICLE
Luca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, Carmen Belli, Elisabetta Setola, Gabriella Parma, Nicola Fusco, Massimo Barberis, Elena Guerini Rocco, Antonio Marra, Nicoletta Colombo, Giuseppe Curigliano
BACKGROUND: Uterine leiomyosarcoma (uLMS) represents one of the most common sarcoma histotypes, demonstrating an overall dismal prognosis. Previous studies reported uLMS to carry recurrent somatic BRCA2 homozygous deletions, related to significant clinical benefits from the use of PARP inhibitors. METHODS: To investigate the prevalence in uLMS of genomic alterations (alt) in BRCA2 and other homologous recombination (HR) and DNA damage response (DDR) genes, cBioPortal was accessed and data were retrieved from studies including pan-sarcoma histologies...
May 8, 2024: Oncologist
https://read.qxmd.com/read/38707732/pleomorphic-rhabdomyosarcoma-of-the-uterine-corpus-in-an-adult-who-underwent-multi-gene-panel-testing
#3
JOURNAL ARTICLE
Tamami Odai, Noriko Oshima, Yusuke Kori, Maki Takao, Kimio Wakana, Naoyuki Miyasaka
BACKGROUND/AIM: Rhabdomyosarcoma (RMS) is the most common malignant soft tissue tumor in children. Adult primary RMS of gynecological origin is a rare condition and uterine RMS is an aggressive malignancy with a poor prognosis. The genetic variants associated with uterine RMS in adults have yet to be fully elucidated, and there is no established therapeutic strategy for rare tumors. CASE REPORT: A 69-year-old Japanese woman was referred to our hospital with abdominal bloating...
2024: Cancer Diagn Progn
https://read.qxmd.com/read/38688662/pegylated-liposomal-doxorubicin-combined-with-trabectedin-as-a-treatment-option-in-uterine-sarcomas-a-single-institution-retrospective-analysis
#4
JOURNAL ARTICLE
Magdalena Steinlechner, Laura Strobel, Katharina Leitner, Teresa L Pan, Barin Feroz, Christian Marth, Alain G Zeimet
OBJECTIVE: The use of conventional doxorubicin in combination with trabectedin leads to a considerable prolongation of progression-free survival in the treatment of uterine sarcomas but is associated with dose-limiting toxicities. Significant progression-free survival improvement was recently obtained through treatment prolongation with trabectedin single agent. We hypothesize that the therapeutic index of pegylated liposomal doxorubicin combined with trabectedin could be superior to the combination with conventional doxorubicin due to a more favorable toxicity profile...
April 30, 2024: International Journal of Gynecological Cancer
https://read.qxmd.com/read/38681981/uterine-adenosarcoma-presenting-as-uterine-inversion-a-case-study
#5
Caitlin Witt, Chelsey Vranes, Leslie H Clark
•Non-puerperal uterine inversion can be associated with uterine sarcomas.•Adenosarcoma is a tumor composed of benign epithelium and malignant stroma.•If malignancy is suspected or confirmed treatment of uterine inversion with hysterectomy is advised.
June 2024: Gynecologic Oncology Reports
https://read.qxmd.com/read/38678330/-clinicopathological-features-of-ntrk-rearranged-spindle-cell-neoplasms-of-the-uterus-of-two-cases
#6
JOURNAL ARTICLE
G M Hu, H P Chen, R Z Zhang, H F Wu
No abstract text is available yet for this article.
May 8, 2024: Zhonghua Bing Li Xue za Zhi Chinese Journal of Pathology
https://read.qxmd.com/read/38672651/machine-learning-applied-to-pre-operative-computed-tomography-based-radiomic-features-can-accurately-differentiate-uterine-leiomyoma-from-leiomyosarcoma-a-pilot-study
#7
JOURNAL ARTICLE
Miriam Santoro, Vladislav Zybin, Camelia Alexandra Coada, Giulia Mantovani, Giulia Paolani, Marco Di Stanislao, Cecilia Modolon, Stella Di Costanzo, Andrei Lebovici, Gloria Ravegnini, Antonio De Leo, Marco Tesei, Pietro Pasquini, Luigi Lovato, Alessio Giuseppe Morganti, Maria Abbondanza Pantaleo, Pierandrea De Iaco, Lidia Strigari, Anna Myriam Perrone
BACKGROUND: The accurate discrimination of uterine leiomyosarcomas and leiomyomas in a pre-operative setting remains a current challenge. To date, the diagnosis is made by a pathologist on the excised tumor. The aim of this study was to develop a machine learning algorithm using radiomic data extracted from contrast-enhanced computed tomography (CECT) images that could accurately distinguish leiomyosarcomas from leiomyomas. METHODS: Pre-operative CECT images from patients submitted to surgery with a histological diagnosis of leiomyoma or leiomyosarcoma were used for the region of interest identification and radiomic feature extraction...
April 19, 2024: Cancers
https://read.qxmd.com/read/38669593/central-necrosis-in-uterine-sarcoma
#8
JOURNAL ARTICLE
C De Bruyn, C Taliento, A-S Van Rompuy, D Timmerman, A Coosemans, T Van den Bosch
No abstract text is available yet for this article.
April 26, 2024: Ultrasound in Obstetrics & Gynecology
https://read.qxmd.com/read/38645533/benign-and-malignant-prolapsed-uterine-tumors-4-case-reports-of-an-extremely-rare-entities
#9
Btissam Benabderrazik, Ghita Lahnine, Amal Akammar, Nizar El Bouardi, Badreddine Alami, Youssef My Alaoui Lamrani, Mustapha Maaroufi, Meryem Boubbou, Meriem Haloua
Prolapsed uterine tumors within the cervix or vagina, are attached to the uterine cavity by a soft tissue stalk. Malignant tumors and leiomyoma are the first diagnostic considerations for a prolapsed uterine mass with a visible stalk at MRI. This article describes 4 cases of patients who presented with large, necrotic prolapsed uterine tumors that were surgically confirmed and were diagnosed prospectively on the basis of MRI findings. Imaging, particularly MRI, plays a crucial role in the management of patients with prolapsed pedunculated uterine tumors, especially for pre-operative localization and surgical treatment...
June 2024: Radiology Case Reports
https://read.qxmd.com/read/38637834/sarcoma-of-the-uterine-cervix-experience-of-a-single-center
#10
JOURNAL ARTICLE
Hua Yuan, Lihong Li, Ning Li, Hongwen Yao
OBJECTIVES: To investigate the clinicopathological characteristics and prognosis of patients with primary sarcoma of the uterine cervix. METHODS: We identified all patients with primary cervical sarcomas treated at our institution from 2002 to 2020 and analyzed the clinicopathological characteristics and prognosis. RESULTS: 34 patients were identified, 7 (20.6%) patients had leiomyosarcoma, 6 (17.6%) had carcinosarcoma, 5 (14.7%) had Ewing sarcoma, 4 (11...
April 18, 2024: World Journal of Surgical Oncology
https://read.qxmd.com/read/38628655/new-treatment-strategies-for-uterine-sarcoma-using-secreted-frizzled%C3%A2-related-proteins
#11
JOURNAL ARTICLE
Tomohiro Kagawa, Ayuka Mineda, Tomotaka Nakagawa, Ayaka Shinohara, Ryosuke Arakaki, Hiroaki Inui, Hiroki Noguchi, Atsuko Yoshida, Riyo Kinouchi, Yuri Yamamoto, Kanako Yoshida, Takashi Kaji, Masato Nishimura, Takeshi Iwasa
Secreted frizzled-related proteins (SFRPs) are involved in the development of various types of cancer and function by suppressing the Wnt signaling pathway. To elucidate the clinical implications of SFRPs in uterine sarcoma, SFRP expression levels and their effects on uterine leiomyosarcoma cells were examined. Immunostaining for SFRP4 was performed on uterine smooth muscle, uterine fibroid and uterine leiomyosarcoma tissues. Additionally, the effects of SFRP4 administration on cell viability, migration and adhesion were evaluated in uterine leiomyosarcoma SKN cells using the WST-1 assay (Roche Diagnostics) and the CytoSelect™ 24-well Cell Migration Assay Kit and the CytoSelect™ 48-well Cell Adhesion Assay Kit...
May 2024: Experimental and Therapeutic Medicine
https://read.qxmd.com/read/38623604/the-other-uterine-mesenchymal-neoplasms-recent-developments-and-emerging-entities
#12
JOURNAL ARTICLE
Jennifer A Bennett, Andre Pinto
Uterine mesenchymal neoplasms are a challenging group of tumors that often show overlapping morphologic features and immunohistochemical profiles. The increasing use of molecular testing in these tumors has enabled a better appreciation of their pathobiology, resulting in a wave of emerging neoplasms and improved characterization of ones previously considered exceptionally rare. Identification of specific molecular alterations has permitted targeted therapy options in tumors that were typically unresponsive to conventional therapies, as well as recognition that a subset can have a hereditary basis...
April 16, 2024: Advances in Anatomic Pathology
https://read.qxmd.com/read/38613349/fibroblast-growth-factor-23-is-a-potential-prognostic-biomarker-in-uterine-sarcoma
#13
JOURNAL ARTICLE
Ling Yang, Ying Cai, Yunjia Wang, Yue Huang, Chi Zhang, Hu Ma, Jian-Guo Zhou
BACKGROUND: Uterine sarcoma (US) is a highly malignant cancer with poor prognosis and high mortality in women. In this study, we evaluated the expression of human fibroblast growth factor 23 (FGF23) in different US subtypes and the relationship between survival and clinicopathological characteristics. METHODS: We conducted a comparative analysis of FGF23 gene expression in different pathological types of US. Utilizing a cohort from The Cancer Genome Atlas of 57 patients, a 50-patient microarray dataset (GSE119043) from the Gene Expression Omnibus and a Suining cohort of 44 patients, we analyzed gene expression profiles and corresponding clinicopathological information...
2024: Technology in Cancer Research & Treatment
https://read.qxmd.com/read/38596477/intravascular-leiomyoma-considered-preoperatively-as-uterine-sarcoma-a-rare-case
#14
Yingyao Wang, Song Xu, Caibo Wang, Wenjuan Li, Jianhao Xu, Zhiwei Zhu, Qin Liu, Lixia Zhu
Intravascular leiomyoma (IVL) is usually defined as a histologically benign leiomyoma that originates in a uterine fibroid or the intrauterine vein wall and grows and expands intravenously. We report a case in which pelvic IVL was detected early and discuss the early diagnosis of and best treatment for this tumor.
2024: Women's health reports
https://read.qxmd.com/read/38580088/e2f-transcription-factor-1-modulates-expression-of-glutamine-metabolic-genes-in-mouse-embryonic-fibroblasts-and-uterine-sarcoma-cells
#15
JOURNAL ARTICLE
Katharina Huber, Albert Giralt, René Dreos, Helene Michenthaler, Sarah Geller, Valentin Barquissau, Dorian V Ziegler, Daniele Tavernari, Hector Gallart-Ayala, Katarina Krajina, Katharina Jonas, Giovanni Ciriello, Julijana Ivanisevic, Andreas Prokesch, Martin Pichler, Lluis Fajas
Metabolic reprogramming is considered as a hallmark of cancer and is clinically exploited as a novel target for therapy. The E2F transcription factor-1 (E2F1) regulates various cellular processes, including proliferative and metabolic pathways, and acts, depending on the cellular and molecular context, as an oncogene or tumor suppressor. The latter is evident by the observation that E2f1-knockout mice develop spontaneous tumors, including uterine sarcomas. This dual role warrants a detailed investigation of how E2F1 loss impacts metabolic pathways related to cancer progression...
April 3, 2024: Biochimica et Biophysica Acta. Molecular Cell Research
https://read.qxmd.com/read/38554313/endometrial-stromal-tumors-a-clinico-histomorphological-spectrum-of-endometrial-stromal-tumors-with-review-of-literature
#16
REVIEW
Ankita Verma, Reena Tomar, Anubhuti Chaturvedi, Nimisha Dhankar, Varuna Mallya, Nita Khurana
BACKGROUND: Endometrial stromal tumors (ESTs) are rare subset of mesenchymal uterine neoplasms. There are heterogeneous morphological, immunohistochemical, and genetic features. Approximately 50% of ESTs occur in perimenopausal women. In 2020, WHO sub-categorized ESTs into four groups: endometrial stromal nodule (ESN), low-grade endometrial stromal sarcoma (LGESS), high-grade endometrial stromal sarcoma (HGESS), and undifferentiated uterine sarcoma (UUS). OBJECTIVE: To review the morphological spectrum of endometrial stromal tumors...
January 1, 2024: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/38549925/case-report-an-atypical-case-of-uterine-adenosarcoma-with-extensive-bizarre-stromal-cells-and-amplification-of-mdm2
#17
Xiaoling Xiao, Ying He
Polypoid lesions in the uterus are very common. There are a lot of benign lesions and malignant tumor should be considered. Adenosarcoma, one of the differential diagnoses, is a rare mixed epithelial and mesenchymal tumor consisting of benign epithelial components and sarcoma stroma. Here, we present a case of atypical adenosarcoma that has never been reported. This tumor was composed of benign endometrial epithelium and hyperplastic stroma with extensive bizarre stromal cells. But the cleft-like spaces and papillary stomal fronds which were the typical histological images of adenosarcoma were absent...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38524654/giant-retroperitoneal-myolipoma-mimicking-liposarcoma-report-of-a-resected-case-and-review-of-the-literature
#18
JOURNAL ARTICLE
Kosuke Mori, Takamichi Igarashi, Akira Noguchi, Miki Ito, Yasuhiro Nagaoka, Chitaru Takeshita, Naoya Takeda, Toru Watanabe, Isaku Yoshioka, Kenichi Hirabayashi, Tsutomu Fujii
Myolipomas are rare tumors that are often difficult to differentiate from liposarcoma. Herein, we report a case of resected giant myolipoma preoperatively diagnosed as liposarcoma. A 63-year-old woman was suspected of having a large retroperitoneal liposarcoma on October 202X. The patient was referred to our department for tumor resection and a histological diagnosis. After consultation with the urology, obstetric and gynecology, and vascular surgery departments, tumor resection was planned, including the potential resection of other organs...
April 2024: International cancer conference journal
https://read.qxmd.com/read/38517559/randomized-controlled-trial-of-an-app-for-cancer-pain-management
#19
RANDOMIZED CONTROLLED TRIAL
Lizhu Weng, Wanlong Lin, Xiuxian Lin, Maobai Liu, Jing Yang
PURPOSE: The primary objective of this investigation was to devise a mobile application for self-management of cancer-related discomfort, with the overarching goal of enhancing patients' overall well-being. Would the utilization of the self-management application result in an amelioration of life quality compared to conventional follow-up procedures? METHODS: Modules were meticulously devised with the collaborative expertise of oncology pain specialists employing the Delphi technique...
March 22, 2024: Supportive Care in Cancer
https://read.qxmd.com/read/38509011/refractory-pneumothorax-due-to-cystic-pulmonary-metastasis-of-a-lowgrade-endometrial-stromal-sarcoma-a-case-report
#20
Hajime Watanabe, Tomoki Nakagawa, Ryota Masuda, Shunsuke Yamada, Masayuki Iwazaki
Low-grade endometrial stromal sarcoma (LG-ESS) is a rare uterine neoplasm. Computed tomography (CT) revealed the presence of multiple small bilateral pulmonary nodules in a 58-year-old woman 1 year after surgery for LG-ESS; the clinical diagnosis was pulmonary metastasis. Hormone therapy with progesterone was initiated, after which most of the solid nodules disappeared and some transformed into cystic lesions. Seven years after hormone therapy, the patient experienced repeated pneumothorax. The cause of the pneumothorax was perforation of a metastatic focus within the wall of a small subpleural cyst that was not evident on CT images...
April 20, 2024: Tokai Journal of Experimental and Clinical Medicine
keyword
keyword
88080
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.